naa a22 4500 510779263 CHVBK 20180411083241.0 cr unu---uuuuu 180411e20130201xx s 000 0 eng 10.1007/s11892-012-0337-9 doi (NATIONALLICENCE)springer-10.1007/s11892-012-0337-9 Role of Continuous Glucose Monitoring in the Management of Diabetic Pregnancy [Elektronische Daten] [Niranjala Hewapathirana, Esther O'Sullivan, Helen Murphy] Self-monitoring of blood glucose (SMBG) with intermittent capillary glucose fingerstick tests is currently the universally accepted method of glucose monitoring in pregnancy. During pregnancy SMBG tests are recommended before and after meals and before bed (typically 7 values/d). Continuous glucose monitoring systems consist of a disposable subcutaneous glucose-sensing device, electrochemically measuring glucose levels in subcutaneous tissues every 10seconds, providing an average interstitial glucose value every 5minutes (typically 288 values/d). From a research perspective this provides unprecedented insights into the pathophysiology of glucose metabolism, while from a clinical perspective it can facilitate enhanced patient-professional decision making, patient motivation, and improved glycaemic control. CGM has thus been described as a "roadmap for effective self-management” and as a "stepping stone in the journey towards a cure.” This review will consider the lessons learned and evidence supporting current and potential future use of CGM in the management of diabetes in pregnancy. Springer Science+Business Media New York, 2012 Type 1 diabetes nationallicence Type 2 diabetes nationallicence Pregnancy nationallicence Continuous glucose monitoring (CGM) nationallicence Continuous glucose monitoring systems (CGMS) nationallicence Self-monitoring of blood glucose (SMBG) nationallicence Pregestational diabetes nationallicence Gestational diabetes nationallicence Hewapathirana Niranjala MRCP, Queens Medical Centre, Nottingham University Hospitals NHS Trust, Derby Road, NG7 2UH, Nottingham, UK aut O'Sullivan Esther University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Hills Road, CB20QQ, Cambridge, UK aut Murphy Helen University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Hills Road, CB20QQ, Cambridge, UK aut Current Diabetes Reports Current Science Inc. 13/1(2013-02-01), 34-42 1534-4827 13:1<34 2013 13 11892 https://doi.org/10.1007/s11892-012-0337-9 text/html Onlinezugriff via DOI 1 review-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s11892-012-0337-9 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Hewapathirana Niranjala MRCP, Queens Medical Centre, Nottingham University Hospitals NHS Trust, Derby Road, NG7 2UH, Nottingham, UK aut NATIONALLICENCE 700 1- O'Sullivan Esther University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Hills Road, CB20QQ, Cambridge, UK aut NATIONALLICENCE 700 1- Murphy Helen University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Hills Road, CB20QQ, Cambridge, UK aut NATIONALLICENCE 773 0- Current Diabetes Reports Current Science Inc 13/1(2013-02-01), 34-42 1534-4827 13:1<34 2013 13 11892 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer